i2b2 – An Improved Tool to Help You Plan Recruitment for Clinical Studies

i2b2 allows researchers to get “counts” of potential study participants in the electronic health records who meet specific inclusion and exclusion criteria.

September 26, 2017

The informatics team at SC CTSI is excited to announce improvements to the study feasibility and recruitment planning website that uses the i2b2 tool. Developed at Harvard and used by multiple academic institutions, i2b2 allows researchers to get “counts” of potential study participants in the electronic health records who meet specific inclusion and exclusion criteria. i2b2 has been live at USC and CHLA since 2016 but now includes data from Los Angeles County health system, more data from Keck Medicine of USC, and faster data delivery.

Uses:

  • Search your study entry criteria to assess feasibility (e.g., age, diagnosis, medications, recent lab results)
  • Refine your target study cohort by modifying your search
  • Request datasets for analysis, screening, or patient contact (with prior approval)

New & Improved:

  • USC data are now refreshed biweekly, giving you a more current picture of potential participants.
  • Data from Los Angeles County health system are now searchable by affiliated researchers
  • Most datasets can be automatically generated by the informatics team, shortening the turnaround time for researchers. Analysts can prepare a dataset with IRB-approved data elements within a week.

Request an i2b2 account by emailing the Clinical Research Informatics team at cri@usc.edu. Give it a try!


Click here to view the FAQs for information about obtaining IRB approval for data requests, i2b2, and other informatics questions BEFORE sending an email for help.

More information about i2b2 is available on the SC CTSI website.

Download informational flyer here

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.